コンテンツへスキップ
Merck
  • Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Bioorganic & medicinal chemistry letters (2010-04-07)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Jae-Kyu Jung, Jerry Xu, Martin C Cherrier, Peter J Webb, Graeme Semple, Carleton R Sage, Jens Knudsen, Ruoping Chen, Andrew K Taggart, Ester Carballo-Jane, Jeremy G Richman
要旨

Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ニコチン酸, ≥99.5% (HPLC)
Sigma-Aldrich
ニコチン酸, ≥98%
Sigma-Aldrich
ニコチン酸, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Supelco
ニコチン酸, analytical standard
Sigma-Aldrich
ニコチン酸, meets USP testing specifications